Clearbridge Health Ltd. · SGX:1H3
Clearbridge Health — Corporate Update (November 2021)
8 slides from Clearbridge Health's corporate update, Nov 5, 2021
Slide 1: Proposed Expansion into New Business
PROPOSED EXPANSION INTO NEW BUSINESS
Slide 2: Important Notice
IMPORTANT NOTICE Clearbridge Health Limited (the “Company”) is a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). This presentation has been prepared by the Company and has been reviewed by the Company’s sponsor, United Overseas Bank Limited (
Slide 3: Proposed Expansion
PROPOSED EXPANSION • The Group’s existing business has delivered a compound annual growth rate of 401.2% in revenue from S$288,000 in 2017 to S$36,258,000 in 2020 • While remaining committed to the existing business, the Group proposes to expand into the business of investing into various entities i
Slide 4: Proposed New Business Overview
PROPOSED NEW BUSINESS OVERVIEW INVEST GROW DIVEST • Portfolio Companies: entities in the global • Provide support to the Portfolio Companies’ • Exit strategies: through mergers and healthcare sectors which are EBITDA operations and business in various areas e.g. acquisitions, listings on public stoc
Slide 5: Rationale of Expansion
RATIONALE OF EXPANSION Potential in the Proposed New Attractive value and opportunities in Additional revenue stream and Enhanced shareholders’ value Business the Proposed New Business flexibility for the Group • Enable the Group to better • Allow the Group to carry out • Additional revenue streams
Slide 6: Management of Proposed New Business
MANAGEMENT OF PROPOSED NEW BUSINESS JEREMY YEE JONATHAN LIAU Executive Director and Chief Executive Officer (CEO) Chief Operating Officer (COO) • Currently responsible for the overall operations of the • Currently responsible for overseeing the commercial Group as its Executive Director and CEO stra
Slide 7: Funding and Risk Factors
FUNDING AND RISK FACTORS Funding for the Proposed New Business • Through a combination of internal resources and external funding such as capital raising, borrowings from financial institutions and other sources • The management will determine the optimal mix of internal and external funding, taking
Slide 8: End of Presentation
END OF PRESENTATION Tel: 6251 0136 Add: 37 Jalan Pemimpin #08-05 Mapex Singapore 577177
Clearbridge Health — Corporate Update (November 2021) on 6ix